Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
denosumab (prolia) (1 trial)
sodium chloride (1 trial)
creatinine (1 trial)
fgf-23 protein, human (2 trials)
Kidney Diseases (Phase 4)
Osteoporosis (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Trials (4 total)
Trial APIs (4 total)